
Pranesh K. Barua
Examiner (ID: 2541, Phone: (571)270-1017 , Office: P/2637 )
| Most Active Art Unit | 2637 |
| Art Unit(s) | 2635, 2637 |
| Total Applications | 554 |
| Issued Applications | 412 |
| Pending Applications | 49 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5338002
[patent_doc_number] => 20090054466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Leukotriene B4 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/180738
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37294
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180738 | Leukotriene B4 inhibitors | Jul 27, 2008 | Issued |
Array
(
[id] => 5361626
[patent_doc_number] => 20090036420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/180566
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17372
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036420.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180566 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | Jul 27, 2008 | Abandoned |
Array
(
[id] => 5361628
[patent_doc_number] => 20090036422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/178688
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35696
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036422.pdf
[firstpage_image] =>[orig_patent_app_number] => 12178688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/178688 | MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | Jul 23, 2008 | Abandoned |
Array
(
[id] => 4779492
[patent_doc_number] => 20080287490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Bis-pyridino containing compounds for the use in the treatment of CNS pathologies'
[patent_app_type] => utility
[patent_app_number] => 12/219190
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16038
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287490.pdf
[firstpage_image] =>[orig_patent_app_number] => 12219190
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/219190 | Bis-pyridino containing compounds for the use in the treatment of CNS pathologies | Jul 16, 2008 | Abandoned |
Array
(
[id] => 6071530
[patent_doc_number] => 20110046381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'NOVEL 4-{3-[4-(3-{4-[AMINO (BUTOXYCARBONYLIMINO) METHYL] PHENOXY} PROPYL)-1-PIPERIDINYL] PROPOXY]-N\'-(BUTOXYCARBONYL) BENZAMIDINE CRYSTALS'
[patent_app_type] => utility
[patent_app_number] => 12/667179
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3923
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667179 | 4-{3-[4-(3-{4-[amino (butoxycarbonylimino) methyl] phenoxy} propyl)-1-piperidinyl] propoxy}-N'-(butoxycarbonyl) benzamidine crystals | Jul 1, 2008 | Issued |
Array
(
[id] => 6328064
[patent_doc_number] => 20100197732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Repaglinide Substantially Free of Dimer Impurity'
[patent_app_type] => utility
[patent_app_number] => 12/663106
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10725
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 65
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197732.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663106
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663106 | Repaglinide Substantially Free of Dimer Impurity | Jun 4, 2008 | Abandoned |
Array
(
[id] => 7683708
[patent_doc_number] => 20100240703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'OXYIMINO COMPOUNDS AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/602441
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39143
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602441 | Oxyimino compounds and the use thereof | May 29, 2008 | Issued |
Array
(
[id] => 8630182
[patent_doc_number] => 08362254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Method for the production of 4-formylaminopiperidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/600303
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6947
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600303
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600303 | Method for the production of 4-formylaminopiperidine derivatives | May 27, 2008 | Issued |
Array
(
[id] => 4699148
[patent_doc_number] => 20080221332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Hindered Amine salt compounds'
[patent_app_type] => utility
[patent_app_number] => 12/150550
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12705
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150550 | Hindered Amine salt compounds | Apr 28, 2008 | Abandoned |
Array
(
[id] => 4950159
[patent_doc_number] => 20080306285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Heat-Labile Prodrugs'
[patent_app_type] => utility
[patent_app_number] => 12/111188
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7639
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306285.pdf
[firstpage_image] =>[orig_patent_app_number] => 12111188
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111188 | Heat-Labile Prodrugs | Apr 27, 2008 | Abandoned |
Array
(
[id] => 4887589
[patent_doc_number] => 20080261921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'FUSED RING HETEROCYCLE KINASE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/101110
[patent_app_country] => US
[patent_app_date] => 2008-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 87197
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101110 | Fused ring heterocycle kinase modulators | Apr 9, 2008 | Issued |
Array
(
[id] => 274387
[patent_doc_number] => 07560553
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-07-14
[patent_title] => 'Use of fuse nicotinamides to promote neurogenesis'
[patent_app_type] => utility
[patent_app_number] => 12/049922
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11598
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12049922
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/049922 | Use of fuse nicotinamides to promote neurogenesis | Mar 16, 2008 | Issued |
Array
(
[id] => 4698970
[patent_doc_number] => 20080221154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 12/043636
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29416
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221154.pdf
[firstpage_image] =>[orig_patent_app_number] => 12043636
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/043636 | HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE | Mar 5, 2008 | Abandoned |
Array
(
[id] => 7796069
[patent_doc_number] => 08124776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Process and intermediates for preparing arzoxifene'
[patent_app_type] => utility
[patent_app_number] => 12/526657
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124776.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526657 | Process and intermediates for preparing arzoxifene | Mar 2, 2008 | Issued |
Array
(
[id] => 4576586
[patent_doc_number] => 07825254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Heteroaromatic quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 12/037964
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35526
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/825/07825254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12037964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037964 | Heteroaromatic quinoline compounds | Feb 26, 2008 | Issued |
Array
(
[id] => 6246115
[patent_doc_number] => 20100136142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'SUBSTITUTED-4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINAMIDES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/526951
[patent_app_country] => US
[patent_app_date] => 2008-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22012
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20100136142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12526951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/526951 | Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | Feb 18, 2008 | Issued |
Array
(
[id] => 4728366
[patent_doc_number] => 20080207910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Process for the preparation of certain substituted sulfilimines'
[patent_app_type] => utility
[patent_app_number] => 12/069627
[patent_app_country] => US
[patent_app_date] => 2008-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4457
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207910.pdf
[firstpage_image] =>[orig_patent_app_number] => 12069627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/069627 | Process for the preparation of certain substituted sulfilimines | Feb 11, 2008 | Issued |
Array
(
[id] => 6222772
[patent_doc_number] => 20100056497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'AMIDE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 12/524921
[patent_app_country] => US
[patent_app_date] => 2008-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79876
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524921
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524921 | AMIDE DERIVATIVE | Jan 29, 2008 | Abandoned |
Array
(
[id] => 4728066
[patent_doc_number] => 20080207610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 12/019034
[patent_app_country] => US
[patent_app_date] => 2008-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 39017
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12019034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/019034 | ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION | Jan 23, 2008 | Abandoned |
Array
(
[id] => 8784870
[patent_doc_number] => 08431713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => '2-aminopyridine derivatives as glucokinase activators'
[patent_app_type] => utility
[patent_app_number] => 12/524327
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16718
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524327
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524327 | 2-aminopyridine derivatives as glucokinase activators | Jan 15, 2008 | Issued |